These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38816974)

  • 1. Emerging Perspectives of YAP/TAZ in Human Skin Epidermal and Dermal Aging.
    Kim JY; Quan T
    Ann Dermatol; 2024 Jun; 36(3):135-144. PubMed ID: 38816974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP/TAZ as Molecular Targets in Skeletal Muscle Atrophy and Osteoporosis.
    Kwon Y
    Aging Dis; 2024 Mar; ():. PubMed ID: 38502585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin.
    Rognoni E; Walko G
    Cells; 2019 May; 8(5):. PubMed ID: 31058846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium.
    Zhang W; Li QQ; Gao HY; Wang YC; Cheng M; Wang YX
    Front Cardiovasc Med; 2022; 9():925254. PubMed ID: 35935626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP and TAZ regulate skin wound healing.
    Lee MJ; Byun MR; Furutani-Seiki M; Hong JH; Jung HS
    J Invest Dermatol; 2014 Feb; 134(2):518-525. PubMed ID: 24108406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying the Geroprotective Properties of YAP/TAZ Signaling Inhibitors on
    Golubev DA; Zemskaya NV; Gorbunova AA; Kukuman DV; Moskalev A; Shaposhnikov MV
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of Exercise in Regulating YAP and TAZ During Cardiomyocytes Aging.
    Limyati Y; Sanjaya A; Lucretia T; Gunadi JW; Biben V; Jasaputra DK; Lesmana R
    Curr Cardiol Rev; 2022; 18(5):24-33. PubMed ID: 35379136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis.
    Islam R; Hong Z
    Mechanobiol Med; 2024 Dec; 2(4):. PubMed ID: 39281415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin signalling regulates YAP and TAZ to control skin homeostasis.
    Elbediwy A; Vincent-Mistiaen ZI; Spencer-Dene B; Stone RK; Boeing S; Wculek SK; Cordero J; Tan EH; Ridgway R; Brunton VG; Sahai E; Gerhardt H; Behrens A; Malanchi I; Sansom OJ; Thompson BJ
    Development; 2016 May; 143(10):1674-87. PubMed ID: 26989177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
    Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
    Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of signaling pathways regulating YAP/TAZ activity.
    Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X
    Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.